当前位置:
X-MOL 学术
›
Nano-Micro Lett.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Bio-Nanocarriers for Lung Cancer Management: Befriending the Barriers
Nano-Micro Letters ( IF 31.6 ) Pub Date : 2021-06-12 , DOI: 10.1007/s40820-021-00630-6 Shruti Rawal 1 , Mayur Patel 1
中文翻译:
用于肺癌管理的生物纳米载体:与障碍交朋友
更新日期:2021-06-13
Nano-Micro Letters ( IF 31.6 ) Pub Date : 2021-06-12 , DOI: 10.1007/s40820-021-00630-6 Shruti Rawal 1 , Mayur Patel 1
Affiliation
-
Due to their multifaceted oncological applications and immense translational potential, the bio-nanocarriers and nano-biodevices are being conceived as a futuristic panacea for cancer.
-
Aspects impeding promising prognosis of lung cancer, various nano-biotools, and their plausible benefits over the conventional nanocarriers for lung cancer management have been briefed upon in this review.
-
Research findings from relevant investigations, perspectives, and stipulations for the overall management of lung cancer have also been deliberated.
中文翻译:
用于肺癌管理的生物纳米载体:与障碍交朋友
-
由于其多方面的肿瘤学应用和巨大的转化潜力,生物纳米载体和纳米生物装置被认为是未来治疗癌症的灵丹妙药。
-
本综述简要介绍了阻碍肺癌预后良好的方面、各种纳米生物工具,以及它们在肺癌治疗中相对于传统纳米载体的合理益处。
-
还审议了肺癌总体管理的相关调查、观点和规定的研究结果。